Company: CHNR
Filing Date: 2025-05-15
Form Type: 424B5
Source: 0001079973-25-000830
Chunk: 85

Company: CHINA NATURAL RESOURCES INC
Filing Date: 2025-05-15
Form: 424B5
Chunk 85
---
 in conjunction with,
and is qualified in its entirety by reference to, our unaudited consolidated financial statements and the notes thereto in our report
on Form 6-K filed with the SEC on November 7, 2022.

| 23 |

Reasons for the Offer and Use of Proceeds

Unless otherwise indicated
in an accompanying prospectus supplement, the net proceeds from the sale of the securities offered hereby will be used for general corporate
purposes. We have not allocated any portion of the net proceeds for any particular use at this time. The net proceeds may be invested
temporarily until they are used for their stated purpose. Specific information concerning the use of proceeds from the sale of any securities
will be included in the prospectus supplement relating to such securities.

Interests of Experts and Counsel

No named expert of or counselor
to us was employed on a contingent basis, or, to our knowledge, owns an amount of our shares (or those of our subsidiaries) which is material
to that person, or has a material, direct or indirect economic interest in us or that depends on the success of the offering.

Offer and Listing Details; Markets

The principal United States
market for our common shares, our only class of outstanding equity securities, is Nasdaq. Our common shares have been listed on Nasdaq
since November 22, 2004, under the symbol “CHNR.” We are not aware of any principal market for any of our securities outside
of the United States.

Plan of Distribution

A discussion of the Plan of
Distribution is included elsewhere in this prospectus under the heading “Plan of Distribution.” Additional information relating
to the plan of distribution covering a specific offering will be contained in the applicable prospectus supplement.

Selling Security Holders

This prospectus does not cover
the resale of securities by selling security holders.

Dilution

The specific transaction or
terms upon which shares covered by this prospectus may be issued is not known at this time. Each time we sell securities covered by this
prospectus, we will provide a prospectus supplement that will contain certain specific information about the terms of that issuance. In
the event that there is substantial disparity between the public offering price of the securities to be issued and the effective cost
to directors or senior management or affiliated persons, of equity securities acquired by them during the last five years, or which they
have the right to acquire, a comparison of the public contribution in the proposed public offering and the effective cash contributions